Logo image of TACT

TRANSACT TECHNOLOGIES INC (TACT) Stock Fundamental Analysis

USA - NASDAQ:TACT - US8929181035 - Common Stock

5.36 USD
0 (0%)
Last: 9/23/2025, 4:30:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to TACT. TACT was compared to 33 industry peers in the Technology Hardware, Storage & Peripherals industry. No worries on liquidiy or solvency for TACT as it has an excellent financial health rating, but there are worries on the profitability. TACT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

TACT had negative earnings in the past year.
TACT had a positive operating cash flow in the past year.
In the past 5 years TACT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: TACT reported negative operating cash flow in multiple years.
TACT Yearly Net Income VS EBIT VS OCF VS FCFTACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

The Return On Assets of TACT (-19.38%) is worse than 69.70% of its industry peers.
TACT has a Return On Equity (-27.59%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -19.38%
ROE -27.59%
ROIC N/A
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
TACT Yearly ROA, ROE, ROICTACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

The Gross Margin of TACT (47.47%) is better than 84.85% of its industry peers.
In the last couple of years the Gross Margin of TACT has remained more or less at the same level.
TACT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
TACT Yearly Profit, Operating, Gross MarginsTACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

7

2. Health

2.1 Basic Checks

TACT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TACT has been increased compared to 1 year ago.
The number of shares outstanding for TACT has been increased compared to 5 years ago.
The debt/assets ratio for TACT is higher compared to a year ago.
TACT Yearly Shares OutstandingTACT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
TACT Yearly Total Debt VS Total AssetsTACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

TACT has an Altman-Z score of 4.22. This indicates that TACT is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.22, TACT is doing good in the industry, outperforming 75.76% of the companies in the same industry.
The Debt to FCF ratio of TACT is 0.50, which is an excellent value as it means it would take TACT, only 0.50 years of fcf income to pay off all of its debts.
TACT's Debt to FCF ratio of 0.50 is amongst the best of the industry. TACT outperforms 90.91% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that TACT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, TACT is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.5
Altman-Z 4.22
ROIC/WACCN/A
WACC8.77%
TACT Yearly LT Debt VS Equity VS FCFTACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

TACT has a Current Ratio of 3.08. This indicates that TACT is financially healthy and has no problem in meeting its short term obligations.
TACT has a Current ratio of 3.08. This is in the better half of the industry: TACT outperforms 78.79% of its industry peers.
TACT has a Quick Ratio of 2.07. This indicates that TACT is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.07, TACT is doing good in the industry, outperforming 78.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 2.07
TACT Yearly Current Assets VS Current LiabilitesTACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

TACT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -160.00%.
Looking at the last year, TACT shows a decrease in Revenue. The Revenue has decreased by -9.09% in the last year.
TACT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.06% yearly.
EPS 1Y (TTM)-160%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)-9.09%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%18.96%

3.2 Future

Based on estimates for the next years, TACT will show a very strong growth in Earnings Per Share. The EPS will grow by 30.94% on average per year.
Based on estimates for the next years, TACT will show a quite strong growth in Revenue. The Revenue will grow by 13.13% on average per year.
EPS Next Y38.8%
EPS Next 2Y30.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.91%
Revenue Next 2Y13.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TACT Yearly Revenue VS EstimatesTACT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
TACT Yearly EPS VS EstimatesTACT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

2

4. Valuation

4.1 Price/Earnings Ratio

TACT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TACT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TACT Price Earnings VS Forward Price EarningsTACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

87.88% of the companies in the same industry are more expensive than TACT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.95
EV/EBITDA N/A
TACT Per share dataTACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as TACT's earnings are expected to grow with 30.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.94%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TACT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TRANSACT TECHNOLOGIES INC

NASDAQ:TACT (9/23/2025, 4:30:01 PM)

5.36

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners56.05%
Inst Owner Change2.47%
Ins Owners4.73%
Ins Owner Change1.31%
Market Cap54.08M
Analysts82.86
Price Target5.1 (-4.85%)
Short Float %0.05%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.2%
Min EPS beat(2)80.39%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)61.24%
Min EPS beat(4)26.47%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)176.94%
EPS beat(12)12
Avg EPS beat(12)263.61%
EPS beat(16)15
Avg EPS beat(16)196.58%
Revenue beat(2)2
Avg Revenue beat(2)11.86%
Min Revenue beat(2)7.79%
Max Revenue beat(2)15.92%
Revenue beat(4)2
Avg Revenue beat(4)2.14%
Min Revenue beat(4)-11.88%
Max Revenue beat(4)15.92%
Revenue beat(8)4
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)5.84%
Revenue beat(16)11
Avg Revenue beat(16)5.73%
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)60%
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.13
P/FCF 8.95
P/OCF 8.8
P/B 1.73
P/tB 1.89
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.6
FCFY11.17%
OCF(TTM)0.61
OCFY11.37%
SpS4.75
BVpS3.1
TBVpS2.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.38%
ROE -27.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.47%
FCFM 12.6%
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
F-Score4
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.5
Debt/EBITDA N/A
Cap/Depr 14.5%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 2.07
Altman-Z 4.22
F-Score4
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)63.1%
Cap/Depr(5y)77.66%
Cap/Sales(3y)1.41%
Cap/Sales(5y)2.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y38.8%
EPS Next 2Y30.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.09%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%18.96%
Revenue Next Year18.91%
Revenue Next 2Y13.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year90.32%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.59%
FCF growth 3YN/A
FCF growth 5Y-15.06%
OCF growth 1Y1.47%
OCF growth 3YN/A
OCF growth 5Y-17.43%